Johnson & Johnson says it will pay out $5.5B in sweeping talc deal that could end decade-long legal battle

Johnson & Johnson ​said on Monday it would pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and ‌other talc products cause ovarian cancer, in a landmark deal that could end a contentious legal battle that has dogged the company for a decade.